David Einhorn - DME Capital Management,
Holding/activity history for Coya Therapeutics Inc (COYA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,335,540 | 0.29 | Add 15.28% | 0.04 | $3.94 | $9,202,027 | SEC |
| 2025 Q4 | 2,025,940 | 0.41 | Add 23.05% | 0.08 | $5.80 | $11,750,452 | SEC |
| 2025 Q3 | 1,646,440 | 0.37 | $5.70 | $9,384,708 | SEC | ||
| 2025 Q2 | 1,646,440 | 0.41 | $5.75 | $9,467,030 | SEC | ||
| 2025 Q1 | 1,646,440 | 0.54 | $6.47 | $10,652,466 | SEC | ||
| 2024 Q4 | 1,646,440 | 0.49 | Add 29.23% | 0.11 | $5.73 | $9,434,101 | SEC |
| 2024 Q3 | 1,274,026 | 0.34 | $6.45 | $8,217,467 | SEC | ||
| 2024 Q2 | 1,274,026 | 0.38 | $6.06 | $7,720,598 | SEC | ||
| 2024 Q1 | 1,274,026 | 0.58 | $9.92 | $12,638,338 | SEC |